Document Detail

Nocturnal Penile Erections: The Role of RigiScan in the Diagnosis of Vascular Erectile Dysfunction.
MedLine Citation:
PMID:  23206346     Owner:  NLM     Status:  In-Data-Review    
Introduction.  To determine the etiology of cases with organic erectile dysfunction (ED), invasive techniques are needed that can induce patient anxiety and disturb test results. Aim.  To find any special patterns of nocturnal penile tumescence and rigidity (NPTR) records in cases of vasculogenic impotence that can differentiate cases of arterial and venous origin without resorting to the more invasive diagnostic tests. Methods.  This study included 95 cases of ED (77 cases with abnormal NPTR records plus 18 cases with normal NPTR). History taking and clinical examination with estimation of serum androgen hormones and postprandial blood glucose were done. All patients were then subjected to the following: NPTR monitoring using RigiScan device (Dacomed Corporation, Minneapolis, MN, USA), pharmacopenile duplex ultrasound examination, and redosing pharmacocavernosometry. According to the results of these tests, patients were classified into four groups: psychogenic, arteriogenic, venogenic, and combined arteriogenic-venogenic ED groups. Receiver operator characteristic (ROC) curve analysis of the different RigiScan parameters of venogenic group vs. the arteriogenic group was done. Best parameters were then retested by using them in prediction of veno-occlusive dysfunction (VOD) in all studied patients. Main Outcome Measures.  Different RigiScan parameters: number of events, duration of best episode, base tumescence, base rigidity, tip tumescence, and tip rigidity. Results.  RigiScan parameters were statistically lower in venogenic than in arteriogenic group and were more correlated with flow to maintain than the peak systolic velocity. ROC curve analysis showed that VOD can be predicted if the duration of the best event is <11.5 minutes (diagnostic accuracy 83.7%) or tip rigidity is <36.5% (diagnostic accuracy 81.6%). On generalizing these values in all patients, duration of best event showed diagnostic accuracy of 88.4%. Conclusion.  VOD can be predicted if duration of the best event of NPTR monitoring is less than 11.5 minutes, but the presence of concomitant arterial dysfunction cannot be excluded. Elhanbly S and Elkholy A. Nocturnal penile erections: The role of RigiScan in the diagnosis of vascular erectile dysfunction. J Sex Med 2012;9:3219-3226.
Samir Elhanbly; Ayman Elkholy
Related Documents :
6087306 - Beta-adrenoceptor and epoprostenol (prostacyclin) responsiveness of lymphocytes in migr...
15301906 - Sydenham's chorea-clinical characteristics of nine patients.
8233546 - A psychosocial and behavioral comparison of reflex sympathetic dystrophy, low back pain...
11721126 - Very high prevalence of right-to-left shunt on transcranial doppler in an italian famil...
24698006 - Iron deficiency and hematological changes in adult patients after fontan operation.
16533536 - Severe strongyloidiasis in corticosteroid-treated patients: case series and literature ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The journal of sexual medicine     Volume:  9     ISSN:  1743-6109     ISO Abbreviation:  J Sex Med     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101230693     Medline TA:  J Sex Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3219-26     Citation Subset:  IM    
Copyright Information:
© 2012 International Society for Sexual Medicine.
Mansoura Faculty of Medicine, Department of Andrology, Mansoura University, Mansoura, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ethical aspects of sexual medicine. Internet, vibrators, and other sex AIDS: toys or therapeutic ins...
Next Document:  Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: ...